Warning

Learn the 10 warning signs of stock fraud and find out what you can do if you think you are a victim.

Read More

Representation

Our team of experienced professionals can provide you with the answers and help that you need.

Read More

Validation

We will fight to restore your dignity, regain your sanity and recoup your losses from stockbroker fraud.

Read More

We Recover Your Money on a Contingency Basis.

1-800-STOCKLOSS or 1-800-333-4567

Stock of the Day

Shares of Splunk Inc. (SPLK) were trading up +3.70 or +8.19 percent to $49.00 per share in premarket trading on Friday, after the company announced better than expected earnings yesterday after the market close. Spunk stock closed at $45.29 per share, down -0.61 or -1.33 percent in Thursday’s regular trading session. San Francisco, California basedRead the full article...

Read the rest of Splunk (SPLK) Shares Up on Better than Expected Earnings at InvestorGuide.com.

Shares of Tekmira Pharmaceuticals Corp. (TKMR) were up +1.97 or +9.97 percent to $21.72 per share in Thursday’s premarket. The company was featured in an article in the UK’s Daily Mail as a potential takeover target following last week’s news of Intermune’s (ITMN) takeover by Swiss pharmaceutical giant Roche. Tekmira stock closed at $19.75 perRead the full article...

Read the rest of Tekmira Pharmaceuticals (TKMR) Stock Up on Rumored Takeover at InvestorGuide.com.

Today’s Top News

These newly launched funds use quantitative methodologies and technical analysis.

Occidental Petroleum's earnings and revenues in second-quarter 2014 surpassed the Zacks Consensus Estimate and increased from the prior-year figures. The outperformance was primarily driven by better realized prices of the products sold and strong domestic production volume as a result of robust contribution from the Californian as well as Permian operations

Pall Corporation is a leading manufacturer and marketer of filtration, separation and purification products. We are reaffirming our Neutral recommendation on Pall with a target price of $89.00

St. Jude's 2014-second quarter adjusted earnings per share rose 6.25% to $1.02 and beat the Zacks Consensus Estimate by a couple of cents as well as its own guidance

Contact Us

 
 

Verification